Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
INKT holding history
MiNK Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INKT overviewAll 13F holders of INKTFull Q4 2025 holdings
- Shares (Q4 2025)
- 67,651
- Value
- $754.3K
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 67,651 | $754.3K | <0.1% | +34,300+102.8% | Added | Holders |
| Q3 2025 | 33,351 | $466.9K | <0.1% | +9,607+40.5% | Added | Holders |
| Q2 2025 | 23,744 | $177.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 23,744 | $205.1K | <0.1% | +326+1.4% | AddedConverted for a 1-for-10 split | Holders |
| Q4 2024 | 234,182 | $163.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 234,182 | $175.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 234,182 | $222.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 234,182 | $212.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 234,182 | $250.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 234,182 | $257.6K | <0.1% | −7,001−2.9% | Reduced | Holders |
| Q2 2023 | 241,183 | $506.5K | <0.1% | +192,076+391.1% | Added | Holders |
| Q1 2023 | 49,107 | $93.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 49,107 | $128.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 49,107 | $104.0K | <0.1% | +49,107 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −10,348−100.0% | Sold out | Holders |
| Q1 2022 | 10,348 | $23.0K | <0.1% | −423−3.9% | Reduced | Holders |
| Q4 2021 | 10,771 | $48.0K | <0.1% | +10,771 | New | Holders |